|

Heart Disease Clinical Trials in Vermont

21 recruiting studies across 1 city

All Trials in Vermont

Phase
Trial Phase Location
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3Burlington
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsPhase 3Burlington
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Burlington
An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisPhase 2Burlington
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Burlington
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Burlington
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Phase 3Burlington
ELEVATE-HFpEF Clinical StudyN/ABurlington
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Burlington
Endocardial Mapping With the CoreMap EP Mapping SystemN/ABurlington
His-Bundle Corrective Pacing in Heart FailureN/ABurlington
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Burlington
Left vs Left Randomized Clinical TrialN/ABurlington
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/ABurlington
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387Phase 2/3Burlington
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Burlington
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Burlington
Product Surveillance Registry—Burlington
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Burlington
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/ABurlington
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/ABurlington

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.